Wikipedia -WSS

Wikipedia

author：focus 2025-09-30 11:06:37 - browse：2343

Dozens of figures stand in Oceania on a 3D map — coverage from STAT — Adobe

The two patients had both died young from heart problems. When researchers looked at their DNA, they spotted another commonality: The two shared a particular version of a gene that helps the heart beat. Perhaps, the researchers thought, the variant could explain their heart conditions.

Genomic datasets indicated the variant was rare, meaning it could be the cause of a rare disease. While most other labs that had seen the variant weren’t sure what it meant, one indicated it was likely disease-causing.

The researchers set out to find out for sure. And after surveying labs around the world, poring through papers, and digging through datasets, the team found that the variant was in fact a harmless spelling of the gene in question. What’s more — it turned out the variant was not so rare after all.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Cybersecurity threat forces Lurie Children's to take systems offline

focus

explore

entertainment

WSS

STAT Readout: Friday, Oct. 20 biotech updates

Why a market frenzy over new weight loss drugs defies logic

其实早在18世纪以来，人们已经发现，追求幸福是一项繁重的负担，一项永远无法完美履行的责任。

Time to name cancers by genetics, not organ of origin, expert says

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Cognito secures funding to test medical device for Alzheimer's

explore

Wikipedia

hotspot

Medical records are filled with copy

Time to name cancers by genetics, not organ of origin, expert says

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Novo Nordisk to expand supply of Wegovy for U.S. patients

Medicare details structure of new drug price negotiation program

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Tori Bowie and the unacceptable rates of Black maternal death

Why a market frenzy over new weight loss drugs defies logic

The cancer drug shortage isn’t new — and neither are the solutions

Cassava Sciences’ Alzheimer’s clinical trials should be halted

focus

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Woodcock on FDA’s accelerated approval and her next chapter

A $475,000 price tag for a new cancer drug: crazy or meh?

Congressmen charge Covid hearing ‘could have been an email’

Roivant's CEO is a star, but biotech's black hole persists

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

focus

explore

entertainment

hotspot